Robert Reid, MD
Hematology & Oncology · Fairfax, VANPI 1790753325
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Myriad Genetic Laboratories, Inc. accounts for 64.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $1,569 and has fallen 72.0% since, to $440 in 2023.
Across 45 payments — averaging $54.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$2K
- Johnson & Johnson$135
- Genentech USA, Inc.$102
- Amgen$102
- Novartis$92
- Merck$63
- plus $375 from 13 others
Across 1 payment — averaging $155,950 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$156K
What the payments were for
- Consulting fees$1,40057%
- Food & beverage$1,00841%
- Education$301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 3 | $1,567 |
| Johnson & Johnson | 6 | $135 |
| Genentech USA, Inc. | 4 | $102 |
| Amgen | 5 | $102 |
| Novartis | 4 | $92 |
| Merck | 4 | $63 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $53 |
| Bayer | 2 | $41 |
| Bristol Myers Squibb | 2 | $40 |
| Incyte Corporation | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Tersera Therapeutics LLC | 1 | $30 |
| Lilly USA, LLC | 2 | $23 |
| AstraZeneca | 1 | $23 |
| Pfizer | 1 | $22 |
| Mirati Therapeutics, Inc. | 1 | $21 |
| Array Biopharma Inc | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PreciseTumor$1,534
How this compares
$2,437 in reported general payments places this provider in the 60th percentile of 293 hematology & oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Fairfax
- William ErshlerFairfax$139K
- Sekwon JangFairfax$56K
- Raymond WadlowFairfax$30K
- Daniel ChongFairfax$15K
- Mohamad SalkeniFairfax$12K
- Ruby KochharHampton$236K
- Victor YazbeckRichmond$190K
- David ChangNewport News$141K
- Yue ZhangVirginia Beach$105K
- Jerome GoldschmidtChristiansburg$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.